Efficacy and safety of bosutinib vs imatinib in Indian and non-Indian patients with newly diagnosed chronic phase chronic myeloid leukemia: Subgroup analysis from the BELA trial

Authors :: Hemant Malhotra
M. V. Ramanan
Eric Leip
Rocco J. Crescenzo
A. Maru
Jorge E. Cortes
Navin Khattry
Carlo Gambacorti-Passerini
Source :: Annals of Oncology. 29:viii367-viii368
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Subgroup analysis
Imatinib
Hematology
Newly diagnosed
Chronic phase chronic myeloid leukemia
Internal medicine
medicine
business
Bosutinib
medicine.drug

Tools